上皮性卵巢癌淋巴结孤立肿瘤细胞的生存与临床病理特征评估
该回顾性队列研究基于美国国家癌症数据库2018至2023年15484例上皮性卵巢癌患者,分析淋巴结孤立肿瘤细胞(ITC)的发病率、特征及生存关联。结果显示ITC总体发生率为1.0%,与更高T分期和低级别浆液性癌相关,但多变量分析中ITC与总生存无统计学显著关联。
要点
- 上皮性卵巢癌区域淋巴结ITC发生率为1.0%。
- ITC发生率随T分期升高而增加,低级别浆液性癌中更高。
- ITC与总生存无统计学显著关联。
核心结论
- 区域淋巴结ITC可能不是上皮性卵巢癌短期生存的预后因素。
研究设计与样本
- 回顾性队列研究,查询美国癌症委员会国家癌症数据库,纳入15484例T1-T3/N0-N0(i+)/M0期上皮性卵巢癌患者。
主要发现
- 157例(1.0%)患者区域淋巴结存在ITC。
- T1、T2、T3期ITC发生率分别为0.5%、1.2%、2.6%;T2 vs T1的aOR为1.90(95%CI 1.21-3.00),T3 vs T1的aOR为3.45(95%CI 2.29-5.20)。
- 低级别浆液性癌ITC发生率4.0%,高级别浆液性癌1.5%,aOR为2.68(95%CI 1.66-4.31)。
- ITC与总生存无统计学显著关联:4年生存率81.0% vs 86.7%,调整后HR 0.94(95%CI 0.58-1.52)。
- 亚组分析结果相似,包括T1期调整后HR 1.26(95%CI 0.40-3.93)。
临床怎么用
- 对于上皮性卵巢癌区域淋巴结ITC,可结合T分期和病理类型综合评估,但不宜仅凭ITC判断短期预后。
局限性
- 回顾性研究设计可能存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess reported incidences, characteristics, and survival associated with isolated tumor cells (ITCs) in epithelial ovarian cancer. METHODS: This retrospective cohort study queried the Commission-on-Cancer's National Cancer Database. The study population included 15,484 patients with epithelial ovarian cancer and American Joint Committee on Cancer classification T1-T3 / N0-N0(i+) / M0 who had lymph node evaluation at primary anti-cancer surgery from 2018 to 2023. Multivariable Cox proportional hazards regression model was created to assess overall survival (OS) associated with ITCs, adjusting for preoperative and intraoperative factors-derived propensity score and further postoperative chemotherapy. RESULTS: A total of 157 (1.0%) patients had ITCs in regional lymph nodes, corresponding to one in 100 patients. Higher T classification was associated with higher incidence rate of ITCs (0.5%, 1.2%, and 2.6% for T1, T2, and T3 classification, respectively; adjusted-odd ratio [aOR] for T2 vs T1, 1.90, 95% confidence interval [CI] 1.21 to 3.00; and aOR for T3 vs T1 3.45, 95%Cl 2.29 to 5.20). Reported incidence rates of ITCs were higher for low-grade serous carcinoma compared to high-grade serous carcinoma (4.0% vs 1.5%, aOR 2.68, 95%Cl 1.66 to 4.31). In multivariable analysis, ITCs were statistically not associated with OS (4-year rates, 81.0% and 86.7%, adjusted-hazard ratio 0.94, 95%Cl 0.58 to 1.52). Results were similar in several subgroups (age < 60, age ≥ 60, T1, T2, and T3 classifications, high-grade serous, and low-grade serous) in exploratory analysis. This included adjusted-hazard ratio of 1.26 (95%CI 0.40 to 3.93) for T1 classification. CONCLUSION: The results of this cohort study suggest that ITCs in the regional lymph node may not be a prognostic factor for short-term survival in epithelial ovarian cancer.
引用
- Lee MW, Friedman EL, Erfani H, et al. Assessment of survival and clinicopathologic characteristics associated with lymph node isolated tumor cells in epithelial ovarian cancer. Gynecol Oncol. 2026. PMID: 41806549. doi:10.1016/j.ygyno.2026.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。